MUSC Health professionals attend 2019 TCT conference

Members of MUSC Health’s Blood & Marrow Transplant (BMT) team at Hollings Cancer Center recently attended the 2019 Transplantation and Cellular Therapy (TCT) Meeting in Houston, Texas, where they presented research abstracts and  Stacey Warneke RN, received the 2019 Oncology Nursing Society Excellence in Blood & Marrow Transplantation Award.

The TCT Meetings are the combined annual meetings of the American Society of Blood and Marrow Transplantation (ASBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR). This event, which took place from February 20-24, allows researchers, clinicians and administrators from a broad range of fields to address the latest developments in hematopoietic cell transplantation and cellular therapy. 

Hollings Cancer Center team members spoke on various topics to address how to improve the treatment and rehabilitation of bone and blood marrow transplant patients.

Elizabeth Williams, MUSC’s BMT Program Quality and Outcomes Manager, spoke at the Foundation for the Accreditation of Cellular Therapy-ASBMT Quality Boot Camp. Her presentation was “BMT After-Hours Call Guidelines,” which discussed one of many of the national best practices the BMT program has been recognized for in 2018-19.

Kathy Edwards PharmD, was an invited speaker for the Beyond Fundamentals of HCT course on “HCT Day +100 and Beyond: Long Term Care Panel Discussion.”  Edwards also updated the chapter on Long-Term Complications and Survivorship.

MUSC’s BMT team also participated in one multi-site clinical trial and one multi-site project that were presented as oral abstracts at the event.

Research abstracts presented were:

• “Large Granular Lymphocytosis after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study,” by Leonard Alsfield M.D., Lauren Pearce FNP, Amarendra Kumar Neppalli M.D., Robert K Stuart M.D. and Brian Hess M.D.
• “A Single Center’s Retrospective Review of Blood Transfusion Following Allogeneic Bone Marrow Donation,” by Stacey Warneke RN, Colleen Butcher, RN,  Brian Hess M.D., Michelle Hudspeth M.D., Jennifer Jaroscak, M.D., Amarendra Kumar Neppalli M.D. and Kathleen Prudhomme.
• “Outcomes Using Narrow Band UVB Phototherapy for Acute Skin Graft Versus Host disease in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients,” by Alan Snyder, Lara Wine Lee, M.D., Jennifer Jaroscak, M.D., Lori Donahoo and Michelle Hudspeth M.D.
• “Case-Control Study of Pneumatosis Intestinalis in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients,” by Mamatha Mandava, M.D., Amy Wahlquist, Jennifer Jaroscak M.D., and Michelle Hudspeth, M.D.
• “Nutritional Assessment in Pediatric Patients with High Risk Neuroblastoma,” by Mamatha Mandava M.D., Hailey Thigpen RD, Julie Heh PharmD, Leah Judd RN, Amanda Littleton RN, Michelle Hudspeth M.D., Jackie Kraveka D.O. and Jennifer Jaroscak M.D.
• “Comparison of Parenteral Nutrition Usage in Pediatric Bone Marrow Transplant Patients with and without Gastrostomy Tubes,” by Julie Heh, PharmD and Haley Thigpen, RD.

Related Links

More MUSC Hollings Cancer Center news

Subscribe to our newsletter

Hollings Horizons magazine